Purple Biotech PPBT
NASDAQ PPBT
$1.51 -0.01 (-0.66%)
At close: Oct 2, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Income from Discontinued Operations (2021)

Updated

Purple Biotech (PPBT) recorded Income from Discontinued Operations of $354,000 in Q4 2021, up 129.9% from the prior quarter.

Analysis

Purple Biotech (PPBT) Income from Discontinued Operations (2021) Analysis & Trends

For FY2021, Purple Biotech reported Income from Discontinued Operations of $642,000.

  • Across earlier years, Income from Discontinued Operations came in at -$627,000 in FY2020 and $485,000 in FY2019.
  • Per Business Quant, the preceding three quarters came in at $154,000 (Q3 2021), -$2,000 (Q2 2021) and $136,000 (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 Purple Biotech 247,575.07 189,575.07 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 354,000.00
Sep 30, 2021 154,000.00
Jun 30, 2021 -2,000.00
Mar 31, 2021 136,000.00
API Access

Purple Biotech Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=PPBT&period=max&api_key=YOUR_API_KEY